beta-lactams has been researched along with Bacterial Endocarditides in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.50) | 18.7374 |
1990's | 8 (20.00) | 18.2507 |
2000's | 12 (30.00) | 29.6817 |
2010's | 8 (20.00) | 24.3611 |
2020's | 9 (22.50) | 2.80 |
Authors | Studies |
---|---|
Camus, M; Cassard, B; Diamantis, S; Flateau, C; Riazi, A | 1 |
Everson, N; Freeman, L; McDaniel, L; Milkovits, A | 1 |
Nicholls, S; Robson, C; Rogers, BA; Sandaradura, I; Stuart, R; Tan, B | 1 |
Albert, R; Caillault, L; Dorel, M; Lalanne, S; Le Bot, A; Lemaignen, A; Revest, M; Tattevin, P; Verdier, MC | 1 |
Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
Arias, CA; Dinh, AQ; Kebriaei, R; Khan, A; Murray, BE; Rice, SA; Rybak, MJ; Singh, KV; Stamper, KC; Tran, TT | 1 |
Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
Aouba, A; Auzou, M; Creveuil, C; de La Blanchardière, A; Franconieri, F; Join-Lambert, O; Labombarda, F; Verdon, R | 1 |
Fisher, MA; Spivak, ES; Timbrook, TT; Tritle, BJ | 1 |
Israel, EN; Knoderer, CA; Nichols, KR; Thomas, CA | 1 |
Basuino, L; Chambers, HF; Choo, EJ; Hamilton, SM; Moise, P | 1 |
Arnold, C; Baddley, J; Bayer, A; Carugati, M; Chu, VH; Delahaye, F; Durante-Mangoni, E; Fernandez-Hidalgo, N; Garcia de la Maria, C; Hannan, MM; Kanafani, Z; Klein, JL; Miro, JM; Murdoch, D; Pericàs, JM; Petti, CA; Wray, D | 1 |
Carugati, M; Chu, VH; Durante-Mangoni, E; Fowler, VG; Garcia-de-la-Mària, C; Kanafani, ZA; Marco, F; Messina, JA; Miró, JM; Moreno, A; Park, L; Pericàs, JM; Sharma-Kuinkel, BK; Tattevin, P; Wray, D | 1 |
Boutoille, D; Caillon, J; Jacqueline, C; Le Mabecque, V; Potel, G | 1 |
Baddour, LM; Fadel, HJ; Steckelberg, JM; Tleyjeh, IM; Wilson, WR | 1 |
Kotsakis, SD; Liakopoulos, A; Petinaki, E; Tzouvelekis, LS; Zerva, L | 1 |
Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
Bricaire, F; Meyssonnier, V | 1 |
Amodio-Groton, M; Hoffman-Roberts, HL; Lamp, KC; Moise, PA; Rashid, M; Rastogi, A; Sakoulas, G; Schweitzer, S; Yoon, MJ | 1 |
Arvieux, C; Desbordes, L; Dupont, M; Flicoteaux, R; Le Tulzo, Y; Michelet, C; Tattevin, P; Tribut, O | 1 |
Bruun, NE; Mellerup, MT; Nielsen, JD | 1 |
Caballero-Granado, FJ; Docobo-Pérez, F; García-Curiel, A; Jiménez-Mejías, ME; Moreno-Maqueda, I; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
Bliziotis, IA; Falagas, ME; Matthaiou, DK | 1 |
Baddour, LM; Steckelberg, JM; Wilson, WR | 1 |
Batard, E; Bugnon, D; Caillon, J; Grossi, O; Jacqueline, C; Le Mabecque, V; Miegeville, AF; Potel, G | 1 |
Anastasopoulos, T; Kofteridis, DP; Kontopodis, E; Panagiotakis, S; Samonis, G | 1 |
Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z | 1 |
Hassoun, A | 1 |
Lerner, AM; Reyes, MP; Smith, F | 1 |
Parker, CW; Shatz, GS; Sullivan, TJ; Wedner, HJ; Yecies, LD | 1 |
Hassan, IJ; Hayek, L | 1 |
Alestig, K; Belin, L; Hogevik, H; Olaison, L | 1 |
Archer, GL; Climo, MW; Patron, RL | 1 |
Moreillon, P | 1 |
Bangsborg, J; Frimodt-Møller, N; Gutschik, E; Westh, H | 1 |
Bille, J; Franciolli, M; Glauser, MP; Moreillon, P | 1 |
Bille, J; Cantoni, L; Franciolli, M; Glauser, MP; Moreillon, P | 1 |
Acred, P; Ferguson, DJ; McColm, AA | 1 |
Abraham, SN; Baddour, LM; Christensen, GD; Hasty, DL; Josephs, JA; Lowrance, JH; Madison, BM; Parisi, JT; Simpson, WA | 1 |
Chambers, HF | 1 |
7 review(s) available for beta-lactams and Bacterial Endocarditides
Article | Year |
---|---|
A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Endocarditis, Bacterial; Humans; Monobactams | 2023 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Rothia spp. infective endocarditis: A systematic literature review.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cardiac Surgical Procedures; Child; Echocardiography; Endocarditis; Endocarditis, Bacterial; Female; Humans; Male; Micrococcaceae; Middle Aged; Treatment Outcome; Young Adult | 2021 |
[Antibiotherapy of infectious endocarditis].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Mycoses; Staphylococcal Infections; Streptococcal Infections | 2012 |
The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Therapy, Combination; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Staphylococcus; Streptococcus; Treatment Outcome | 2006 |
Antimicrobial treatment of Capnocytophaga infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests | 2007 |
Endocarditis caused by Kingella denitrificans.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Kingella; Male; Middle Aged; Neisseriaceae Infections | 1993 |
1 trial(s) available for beta-lactams and Bacterial Endocarditides
Article | Year |
---|---|
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
32 other study(ies) available for beta-lactams and Bacterial Endocarditides
Article | Year |
---|---|
Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
Topics: Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Humans; Streptococcal Infections; Streptococcus | 2021 |
Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillins; Retrospective Studies | 2022 |
Amoxicillin therapeutic drug monitoring for endocarditis: A comparative study (EI-STAB).
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Drug Monitoring; Endocarditis; Endocarditis, Bacterial; Enterococcus; Humans; Male; Middle Aged; Retrospective Studies; Streptococcus | 2023 |
Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cephalosporins; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Ertapenem; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rats; Sequence Alignment; Transcriptome | 2020 |
Penicillin as a Potential Agent for Dual β-Lactam Therapy for Enterococcal Endocarditis.
Topics: Anti-Bacterial Agents; beta-Lactams; Endocarditis; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Penicillins; Sepsis | 2020 |
Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Endocarditis, Bacterial; Humans; Practice Guidelines as Topic; United States; Vancomycin | 2016 |
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
Topics: Animals; beta-Lactams; Ceftriaxone; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Ertapenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rabbits | 2016 |
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.
Topics: Aged; beta-Lactams; Coagulase; Cohort Studies; Endocarditis, Bacterial; Female; Hospital Mortality; Humans; Male; Methicillin; Middle Aged; Prospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin | 2016 |
Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the Internationa
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Multiplex Polymerase Chain Reaction; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin; Virulence Factors | 2017 |
In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Colony Count, Microbial; Endocarditis, Bacterial; Female; Humans; Membrane Transport Proteins; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2009 |
Evaluation of antibiotic therapy following valve replacement for native valve endocarditis.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Retrospective Studies; Rifampin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Endocarditis, Bacterial; Female; Humans; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcal Infections; Staphylococcus lugdunensis | 2012 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Creatine Kinase; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Registries; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2013 |
Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Endocarditis, Bacterial; Female; Gram-Positive Cocci; Humans; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2005 |
[Increased bleeding tendency induced by beta-lactam antibiotics].
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Gentamicins; Hemorrhage; Humans; Male; Middle Aged; Penicillins; Shock, Septic | 2005 |
Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ceftriaxone; Endocarditis, Bacterial; Half-Life; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2005 |
Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Meta-Analysis as Topic | 2006 |
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Infective Agents; beta-Lactams; Drug Synergism; Endocarditis, Bacterial; Ertapenem; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Staphylococcaceae; Vancomycin | 2006 |
Treatment of Staphylococcus aureus prosthetic valve endocarditis.
Topics: Aminoglycosides; beta-Lactams; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Endocarditis, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas Infections | 1984 |
Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Desensitization, Immunologic; Drug Hypersensitivity; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Oxacillin; Penicillins; Pneumonia; Pseudomonas Infections; Staphylococcal Infections | 1982 |
Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Drug Hypersensitivity; Endocarditis, Bacterial; Eosinophils; Female; Hemagglutination Tests; Hospitals, University; Humans; Hypersensitivity, Delayed; Incidence; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Penicillins; Prospective Studies | 1999 |
Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus; Vancomycin | 1999 |
[Experimental models: interactions Synercid and beta-lactam antibiotics].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Rats; Staphylococcal Infections; Virginiamycin | 2001 |
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Endocarditis, Bacterial; Haemophilus; Humans; Microbial Sensitivity Tests; Tobramycin | 1992 |
Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Binding, Competitive; Carrier Proteins; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillinase; Peptidyl Transferases; Protein Binding; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Endocarditis, Bacterial; Humans; Methicillin Resistance; Rabbits; Rats; Staphylococcal Infections; Staphylococcus aureus | 1991 |
A morphological comparison of treatment with different beta-lactam antibiotics on experimental staphylococcal endocarditis and aortitis.
Topics: Animals; Anti-Bacterial Agents; Aorta; Aortic Valve; Aortitis; beta-Lactams; Endocarditis, Bacterial; Rabbits; Staphylococcal Infections | 1990 |
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Culture Media; Disease Models, Animal; Drug Resistance, Microbial; Endocarditis, Bacterial; Male; Mice; Microscopy, Electron; Mutation; Phagocytosis; Phenotype; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Urinary Tract Infections; Virulence | 1990 |
Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Carrier Proteins; Coagulase; Electrophoresis, Polyacrylamide Gel; Endocarditis, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptide Mapping; Peptidyl Transferases; Rabbits; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Staphylococcus | 1987 |